1454GCC: Anti-PD-1 (MK-3475) and IMiD (Pomalidomide) Combination Immunotherapy in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT02289222 · TERMINATED
Trial details
- NCT number
- NCT02289222
- Sponsor
- Ashraf Badros
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-30
- Primary completion
- 2017-08-07
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.